ReviewFrontiers in oncology2022

Bruton's tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review.

Jing Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.